Evidence map›Paper›PMID 40584032›Full record

SynthesisFrontiers in microbiology2025

Clinical

Jun-Li Wang, Ya-Li Chen, Cui-Ping Guan, Kan Yu, Mao-Shui Wang

Abstract readSystematic Review
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in Frontiers in microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. A Case of Transmission of Bedaquiline- and Linezolid-Resistant Tuberculosis.International journal of molecular sciences · 2026
    Article
  3. Article
  4. Genomic landscape ofNew microbes and new infections · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jun-Li WangDepartment of Lab Medicine, The Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China.
Ya-Li ChenDepartment of Lab Medicine, Shandong Public Health Clinical Center, Shandong University, Jinan, China.
Cui-Ping GuanDepartment of Lab Medicine, Shandong Public Health Clinical Center, Shandong University, Jinan, China.
Kan YuMarshall Centre, Division of Infection and Immunity, School of Biomedical Sciences, University of Western Australia, Perth, WA, Australia.
Mao-Shui WangDepartment of Lab Medicine, Shandong Public Health Clinical Center, Shandong University, Jinan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Tuberculosis (TB) remains a significant global health concern, necessitating effective measures to control the epidemic. Understanding the evolution of Results: A total of 27 studies were included for analysis. The pooled mutation rate was estimated at 0.63 single nucleotide polymorphisms (SNPs) per genome per year [95% confidence interval (CI): 0.51-0.75; 95% predictive interval (PI): 0.04-1.22], significant heterogeneity (I Conclusion: The mutation rate of clinical Systematic review registration: PROSPERO, identifier CRD42024595161.

Indexed as

heterogeneitymolecular clockMycobacterium tuberculosissingle nucleotide polymorphismsystematic review

Identifiers

PMID40584032
PMCPMC12202658

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.